NCT06158763

Brief Summary

This study aims to (1) develop a CBT-based transcultural, transdiagnostic interactive web app and (2) assess the feasibility, acceptability, and preliminary efficacy of this intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

September 1, 2023

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 6, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2024

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2024

Completed
Last Updated

November 19, 2025

Status Verified

November 1, 2025

Enrollment Period

2.2 years

First QC Date

September 1, 2023

Last Update Submit

November 15, 2025

Conditions

Keywords

CBTweb applicationdepressionanxietyself-help manual

Outcome Measures

Primary Outcomes (2)

  • Feasibility of CBT-based transcultural, transdiagnostic interactive web app will be assessed

    Feasibility \\will be assessed through trial procedure, recruitment, retention and informal feedback from participants.

    12 weeks

  • Acceptability of CBT-based transcultural, transdiagnostic interactive web app will be assessed

    Acceptability will be assessed through trial procedure, recruitment, retention and informal feedback from participants.

    12 weeks

Secondary Outcomes (2)

  • Clinical Measures

    12 weeks

  • The WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)

    12 weeks

Study Arms (2)

Experimental Group

EXPERIMENTAL

In the experimental group, a web-based application intervention will be provided.

Behavioral: Web-based CBT guided self-help Interventions

Control Group

NO INTERVENTION

In the control group, the patients screened for depression or anxiety received treatment as usual (TAU). TAU consisted of standard care under the responsible family physician. TAU in low-income countries largely consists of pharmacological treatment with anti-depressant medication and follow-up in an outpatient clinic.

Interventions

An existing CBT-based transdiagnostic self-help manual (Naeem et al., 2014) that has been used successfully in RCTs (Amin et al., 2020; Naeem et al., 2014) and has been used as an online intervention (http://khushiorkhatoon.com/) will be further adapted. The intervention consists of seven modules, including cognitive restructuring, problem-solving and behavioural activation.

Experimental Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals aged 18 to 65 years
  • At least 5 years of education
  • Computer literate
  • Owning a smartphone or a personal computer with a reliable internet connection
  • Score of 8 or higher on Hospital Anxiety and Depression Scale-Depression or Anxiety scales as measured by their primary care clinician.

You may not qualify if:

  • Substance use disorder according to DSM-5 criteria
  • Significant cognitive impairment (for example, profound learning disability or dementia)
  • Active psychosis as determined by their primary care clinician

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pakistan Association of Cognitive Therapists

Lahore, Punjab Province, 54000, Pakistan

Location

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: This will be a randomized controlled trial to evaluate the feasibility and acceptability of delivering a new intervention. Participants who meet the inclusion criteria will be randomly allocated to intervention or control groups in a 1:1 ratio.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2023

First Posted

December 6, 2023

Study Start

November 1, 2021

Primary Completion

January 31, 2024

Study Completion

October 1, 2024

Last Updated

November 19, 2025

Record last verified: 2025-11

Locations